bioRxivCancer Biology
Multi-omic analysis of CIC's functional networks reveals novel interaction partners and a potential role in mitotic fidelity
Y. Takemon, V. G. LeBlanc, J. Song, S. Y. Chan, S. D. Lee, D. L. Trinh, S. T. Ahmad, W. R. Brothers, R. D. Corbett, A. Gagliardi, A. Moradian, J. G. Cairncross, S. Yip, S. A. Aparicio, J. A. Chan, C. S. Hughes, G. B. Morin, S. M. Gorski, S. Chittaranjan, M. A. Marra
Abstract
CIC encodes a transcriptional repressor and MAPK signalling effector that is inactivated by loss-of-function mutations in several cancer types, consistent with a role as a tumour suppressor. Here, we used bioinformatic, genomic, and proteomic approaches to investigate CICs interaction networks. We observed both previously identified and novel candidate interactions between CIC and SWI/SNF complex members, and also observed novel interactions between CIC and cell cycle regulators and RNA processing factors. We found that CIC loss is associated with an increased frequency of mitotic defects in human cell lines and an in vivo mouse model and with dysregulated expression of mitotic regulators. We also observed aberrant splicing in CIC-deficient cell lines predominantly at 3 and 5 untranslated regions of genes, including genes involved in MAPK signalling, DNA repair, and cell cycle regulation. Our study thus characterises the complexity of CICs functional network and describes the effect of its loss on cell cycle regulation, mitotic integrity, and transcriptional splicing, thereby expanding our understanding of CICs potential roles in cancers. In addition, our work exemplifies how multi-omic, network-based analyses can be used to uncover novel insights into the interconnected functions of pleiotropic genes/proteins across cellular contexts. Simple summaryCapicua (CIC) is a gene that is frequently mutated in several cancer types, including stomach cancers and certain subtypes of brain tumours and sarcomas. CIC, the protein encoded by the CIC gene, has been shown to play a multitude of roles in both normal and cancer cell functions; however, most studies exploring these roles focus on a single aspect of CIC function and may therefore overlook complex interconnected activities in which CIC is involved. In this study, we have used multiple complementary approaches to obtain a broader view of CICs complex functional networks. We observed novel interactions (genetic or physical) between CIC and genes/proteins involved in various aspects of cellular function, including regulation of cell division and processing of RNA molecules. Altogether, our work characterises the complexity of CICs functional network and expands our understanding of its potential roles in cancer.
- organism: human
- organism: mouse
- assay: proteomics
- assay: bulk RNA-seq
- assay: DNA methylation
- research focus: cell type annotation
- research focus: clustering
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: biophysical modeling
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor suppressor Hypermethylated in Cancer 1 represses expression of cell cycle regulator E2F7 in human primary cells
L. Lanikova, J. Svec, … V. Korinek·bioRxiv·Jul 25, 2022
- Cryptococcus neoformans Slu7 ensures nuclear positioning during mitotic progression through RNA splicing
V. P. Krishnan, M. S. Negi, … U. Vijayraghavan·bioRxiv·Nov 23, 2023
- Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
E. A. Raupach, K. Garcia-Mansfield, … P. Pirrotte·bioRxiv·Oct 6, 2019
- Mitotic CDK4/6 activity sustains spindle checkpoint signalling to prevent mitotic slippage and genomic instability
Zhaoru Zhang, Yang Li, … Yuu Kimata·bioRxiv·Sep 13, 2025
- The minor spliceosome offers a therapeutically viable target for the treatment of a broad spectrum of cancers
K. Doggett, K. J. Morgan, … J. K. Heath·bioRxiv·Dec 9, 2021
- mSWI/SNF interacts with the ribosome and its inhibition/mutations alter translation and sensitize to mTOR/PI3K inhibitors
L. Ulicna, S. C. Kimmey, … C. Van Rechem·bioRxiv·May 10, 2021